Cargando…
Secondary Organising Pneumonia Caused by Denosumab
INTRODUCTION: Organising pneumonia belongs to diffuse interstitial lung diseases; we distinguish the cryptogenic organising pneumonia, which is idiopathic, from the secondary organising pneumonia caused by drugs or a defined cause. Denosumab is a human monoclonal antibody, rarely inducing adverse pu...
Autores principales: | Ouakidi, Djalaleddine, Bourouis, Bouchra Nesrine, Banat, Mohammed Amine, Azzi, Nesrine, Benzait, Siham, Snouber, Abdelmadjid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545148/ https://www.ncbi.nlm.nih.gov/pubmed/37789975 http://dx.doi.org/10.12890/2023_004043 |
Ejemplares similares
-
Tocilizumab: Secondary organising pneumonia: case report
Publicado: (2022) -
Refractory Shock Secondary to Denosumab-induced Severe Hypocalcaemia
por: Eshak, Nouran, et al.
Publicado: (2022) -
Severe Refractory Hypocalcemia Caused by Denosumab
por: Dadana, Sriharsha, et al.
Publicado: (2023) -
Rituximab: COVID‐19 infection complicated by secondary organising pneumonia: case report
Publicado: (2022) -
Secondary organising pneumonia to persistent SARS-CoV-2 infection in immunocompromised patient
por: Granados, Galo David, et al.
Publicado: (2022)